PHA SCR spike protein Furin
(Die Seite wurde neu angelegt: „{{up|PHA pharmacophore by screened target}} {{tp|p=32532959|t=2020. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the…“)
Aktuelle Version vom 27. April 2021, 16:45 Uhr
PHA pharmacophore by screened target |
32532959 2020. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin.
32821033 2020. SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients.
32964551 2020. Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS-CoV-2 drug targets: in vitro validation of furin inhibition.
33007239 2020. Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.
33043282 2020. Furin: A Potential Therapeutic Target for COVID-19.
33169107 2020. Synergy of melanin and vitamin-D may play a fundamental role in preventing SARS-CoV-2 infections and halt COVID-19 by inactivating furin protease.